Form 4: Vertex Pharmaceuticals EVP Charles Wagner Jr. Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Charles Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, sold 3,250 shares of common stock at $454.79 per share on May 28, 2024, under a pre-arranged trading plan.
Summary
- Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, sold 3,250 shares of common stock on May 28, 2024.
- The sale was executed at a price of $454.79 per share.
- The transaction was conducted under a company-approved trading plan pursuant to Rule 10b5-1, which was established on February 26, 2024.
- Following the transaction, Wagner directly owns 50,387 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a stock sale by an executive under a pre-arranged trading plan. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales by executives are a normal part of executive compensation and wealth management. The use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Date Mr. Wagner's company approved trading plan under Rule 10b5-1 was entered into. |
| 05/28/2024 | Date of the transaction: sale of 3,250 shares of common stock. |
| 05/30/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.